Information updates

Voluntary recall of specific batches of ALK Peanut SPT in Australia

AMLS is voluntarily withdrawing specific batches of ALK peanut allergenic extract for diagnostic skin prick testing (SPT) in Australia. AMSL will collect affected batches and will provide replacement products. All existing stock has been removed from the AMSL inventory and will be returned to ALK. 

ALK-Abelló, Inc. has been made aware of multiple adverse events from Allergists in Australia resulting from diagnostic SPT using specific batches of ALK Peanut SPT product in 5mL and 10mL packaging configurations at 1:10 w/v. Information on the specific batches is included in this document pdfMarket Withdrawl Letter for Peanut Diagnostic177.98 KB.

According to these reports, individuals who were test-negative using the above product lots subsequently experienced allergic reactions to peanut. 

If there are any questions, contact the AMSL Allergy team:

Ph +61 (02) 9882 3666 | +61 (0)448 022 855

amsl.com.au | LinkedIn

2 McCabe Place, Chatswood NSW 2067

PO Box 5197 Chatswood West NSW 1515

This news item was issued on 16 December 2022 by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand. 

Mod ASCIA Member
Donate to AIFA
go to NAC website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia